Press Releases

The Tredegar facility is our development and manufacturing Center of Excellence with specialist expertise in the processing of highly potent molecules. The site has undergone significant investments over recent years; this latest project ensures analytical capacity and capability to...

Novartis announced the launch of two new Joint Working Projects with National Cancer Vanguard sites, which aim to identify ways to improve cancer patient care pathways and access to services. The projects will be based at The Christie in...

Novartis announced the launch of two new Joint Working Projects with National Cancer Vanguard sites, which aim to identify ways to improve cancer patient care pathways and access to services. The projects will be based at The Christie in...

Micell® Technologies, Inc., a privately-held, development-stage biomedical company, today provided an update on its recently expanded intellectual property portfolio. With the granting of 24 patents in 2017, including eight that issued in the fourth quarter, Micell's extensive intellectual property...

INVICTUS MD STRATEGIES CORP. is pleased to announce that , Gene Simmons, Chief Evangelist Officer for the company and its management team opened the trading day at the TSX Venture Exchange (TSXV). The appearance coincides with the company changing...

Envigo is investing in an expansion of its surgical facility at its Livermore, California site in response to large market demand from West Coast customers. The new expanded capabilities will help create a West Coast Centre...

Agendia, Inc., a world leader in personalized medicine and molecular cancer diagnostics, announces that its next-generation sequencing (NGS)-based MammaPrint® BluePrint® Breast Cancer Recurrence and Molecular Subtyping Kit is now CE marked, enabling the Company to commercialize the device in...